This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of McKesson Corp. (MCK) rose 1.36% to $747.23 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&amp;P 500 Index rising 0.77% to 7,501.24 and the Dow Jones Industrial Average rising 0.75% to 50,063.46.
This was the stock's third consecutive day of gains.
McKesson Corp. closed 25.20% short of its 52-week high of $999.00, which the company reached on March 3rd.
The stock outperformed some of its competitors Thursday, as Amazon.com Inc. (AMZN) fell 1.08% to $267.22, UnitedHealth Group Inc. (UNH) fell 0.52% to $399.09, and CVS Health Corp. (CVS) fell 0.98% to $97.15.
Trading volume (921,594) eclipsed its 50-day average volume of 909,974.
Data source: Dow Jones Market Data, FactSet. Data compiled May 14, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-14-26 1640ET

LABU

McKesson Corp. (MCK) shares rose 1.36% to $747.23 on a positive trading day, outperforming competitors like Amazon, UnitedHealth, and CVS. This marks the third consecutive day of gains for McKesson, although it remains 25.20% below its 52-week high of $999.00 reached on March 3rd. The trading volume was 921,594, surpassing the 50-day average of 909,974.

MarketWatch Automated

McKesson

iShares US Medical Devices

Direxion S&P Biotech Bull 3X

VanEck Biotech ETF

iShares US Pharma

VanEck Pharmaceutical ETF

SPDR S&P Health Equip

First Trust NYSE Arca Biotech Index Fd

Invesco Pharmaceuticals ETF

SPDR S&P Biotech

Invesco Biotechnology & Genome ETF

iShares Biotechnology ETF

ALPS Medical Breakthrough

Proshares Ultra Nasdaq Biotech

SPDR Pharmac

S&P 500

Dow Jones Industrial Average

Amazon

Unitedhealth

CVS Health

Factset Research

McKesson Corp. Stock Outperforms Competitors On Strong Trading Day